XML 21 R12.htm IDEA: XBRL DOCUMENT v3.23.3
Leases
9 Months Ended
Sep. 30, 2023
Leases [Abstract]  
Leases Leases
The Company's operating leases are primarily for real estate, including medical office buildings, and corporate and other administrative offices. The Company's finance leases are primarily for medical equipment and information technology and telecommunications assets.
The following table presents the components of the Company's right-of-use assets and liabilities related to leases and their classification in the consolidated balance sheets (in millions):
Classification in Consolidated Balance SheetsSeptember 30, 2023December 31, 2022
Assets:
Operating lease assetsRight-of-use operating lease assets$244.5 $279.1 
Finance lease assetsProperty and equipment, net of accumulated depreciation571.8 529.6 
Total leased assets$816.3 $808.7 
Liabilities:
Operating lease liabilities:
CurrentOther current liabilities$35.7 $36.5 
Long-termRight-of-use operating lease liabilities240.9 271.4 
Total operating lease liabilities276.6 307.9 
Finance lease liabilities:
CurrentCurrent maturities of long-term debt24.7 20.9 
Long-termLong-term debt, less current maturities616.5 564.8 
Total finance lease liabilities641.2 585.7 
Total lease liabilities$917.8 $893.6 
During the nine months ended September 30, 2023, the Company extended certain existing facility real estate leases, resulting in the reclassification of the leases from operating to finance. The modifications resulted in an increase to finance lease liabilities and assets of $97.1 million and $95.7 million, respectively, including the reclassification of existing operating lease liabilities and assets of $38.4 million and $36.9 million, respectively.
The following table presents the components of the Company's lease expense included in the condensed consolidated statement of operations (in millions):
Nine Months Ended September 30,
20232022
Operating lease costs$48.7 $49.5 
Finance lease costs:
Amortization of leased assets29.0 28.2 
Interest on lease liabilities35.9 30.6 
Total finance lease costs64.9 58.8 
Variable and short-term lease costs16.3 13.7 
Total lease costs$129.9 $122.0 
The following table presents supplemental cash flow information (dollars in millions):
Nine Months Ended September 30,
20232022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash outflows from operating leases $47.2 $47.9 
Operating cash outflows from finance leases$34.1 $30.2 
Financing cash outflows from finance leases$19.3 $18.1 
Right-of-use assets obtained in exchange for lease obligations:
Operating leases$39.9 $45.3 
Finance leases$108.7 $172.5 
Leases Leases
The Company's operating leases are primarily for real estate, including medical office buildings, and corporate and other administrative offices. The Company's finance leases are primarily for medical equipment and information technology and telecommunications assets.
The following table presents the components of the Company's right-of-use assets and liabilities related to leases and their classification in the consolidated balance sheets (in millions):
Classification in Consolidated Balance SheetsSeptember 30, 2023December 31, 2022
Assets:
Operating lease assetsRight-of-use operating lease assets$244.5 $279.1 
Finance lease assetsProperty and equipment, net of accumulated depreciation571.8 529.6 
Total leased assets$816.3 $808.7 
Liabilities:
Operating lease liabilities:
CurrentOther current liabilities$35.7 $36.5 
Long-termRight-of-use operating lease liabilities240.9 271.4 
Total operating lease liabilities276.6 307.9 
Finance lease liabilities:
CurrentCurrent maturities of long-term debt24.7 20.9 
Long-termLong-term debt, less current maturities616.5 564.8 
Total finance lease liabilities641.2 585.7 
Total lease liabilities$917.8 $893.6 
During the nine months ended September 30, 2023, the Company extended certain existing facility real estate leases, resulting in the reclassification of the leases from operating to finance. The modifications resulted in an increase to finance lease liabilities and assets of $97.1 million and $95.7 million, respectively, including the reclassification of existing operating lease liabilities and assets of $38.4 million and $36.9 million, respectively.
The following table presents the components of the Company's lease expense included in the condensed consolidated statement of operations (in millions):
Nine Months Ended September 30,
20232022
Operating lease costs$48.7 $49.5 
Finance lease costs:
Amortization of leased assets29.0 28.2 
Interest on lease liabilities35.9 30.6 
Total finance lease costs64.9 58.8 
Variable and short-term lease costs16.3 13.7 
Total lease costs$129.9 $122.0 
The following table presents supplemental cash flow information (dollars in millions):
Nine Months Ended September 30,
20232022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash outflows from operating leases $47.2 $47.9 
Operating cash outflows from finance leases$34.1 $30.2 
Financing cash outflows from finance leases$19.3 $18.1 
Right-of-use assets obtained in exchange for lease obligations:
Operating leases$39.9 $45.3 
Finance leases$108.7 $172.5